Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. by Christodoulides, C, Dyson, P, Sprecher, D, Tsintzas, K, Karpe, F

The PPARdelta agonist GW501516: Influence on features of the metabolic syndrome by Sprecher, D, Riserus, U, Hirschberg, S, Hassall, D, Olson, E, Sarov-Blat, L, O'Rahilly, S, Willson, T, Murgatroyd, P, Johnson, A, Frayn, K, Karpe, F

Inhibition of p38 Mitogen-Activated Protein Kinase Attenuates Vascular and Systemic Inflammation in Patients with Atherosclerosis as Assessed by 18-F Fluorodeoxyglucose PET-CT by Elkhawad, M, Rudd, J, Sarov-Blat, L, Marber, M, Choudhury, R, Davies, L, Collier, D, Cai, G, Willette, R, Gleeson, F, Lepore, J, Davis, B, Wilkinson, I, Sprecher, D, Cheriyan, J

Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. by Elkhawad, M, Rudd, J, Sarov-Blat, L, Cai, G, Wells, R, Davies, L, Collier, D, Marber, MS, Choudhury, R, Fayad, Z, Tawakol, A, Gleeson, F, Lepore, J, Davis, B, Willette, R, Wilkinson, I, Sprecher, D, Cheriyan, J

PPAR-delta activation reverses multiple metabolic abnormalities, reduces oxidative stress and promotes fat oxidation in obese humans by Riserus, U, Sprecher, D, Jonson, T, Olson, E, Hirschberg, S, Fang, Z, Hegde, P, Richards, D, Sarov-Blat, L, Strum, J, Cheeseman, J, Fielding, B, Moore, N, Murgatroyd, P, O'Rahilly, S, Sutton, P, Willson, T, Hassall, D, Keith, F, Karpe, F

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxida... by Risérus, U, Sprecher, D, Johnson, T, Olson, E, Hirschberg, S, Liu, A, Fang, Z, Hegde, P, Richards, D, Sarov-Blat, L, Strum, J, Basu, S, Cheeseman, J, Fielding, B, Humphreys, S, Danoff, T, Moore, N, Murgatroyd, P, O'Rahilly, S, Sutton, P, Willson, T, Hassall, D, Frayn, K, Karpe, F